Back to Agenda
Panel Debate: What Will the Future Landscape of Biosimilars Look Like and How Should We Prepare for that?
Session Chair(s)
Steffen Thirstrup, MD
Chief Medical Officer, European Medicines Agency, Netherlands
Continuing from the previous sessions, the panel discussion will allow a stakeholder debate on status quo and discuss how the governance framework could facilitate better understanding and acceptance of biosimilars challenged by counter-arguments.
Speaker(s)
Biosimilars - the Physicians' Learning Curve
Paul Cornes, MD
Oncologist, Bristol Oncology Centre, United Kingdom
Leon van Aerts, PhD
, Medicines Evaluation Board, The Netherlands, Netherlands
Thijs Giezen, PharmD, PhD, MSc
, Medicines Evaluation Board, Netherlands
Pekka T Kurki, MD, PhD
Research Professor, Finnish Medicines Agency, Finland
Have an account?